NASDAQ
02.10.25 | 21:43
3,790 US-Dollar
-1,17 % -0,045
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.09. | ForCast Orthopedics And KORU Medical Partner On Novel Antibiotic Infusion Therapy | 3 | RTTNews | ||
| 18.09. | ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy | 213 | ACCESS Newswire | DENVER, CO AND MAHWAH, NJ / ACCESS Newswire / September 18, 2025 / ForCast Orthopedics, Inc. and KORU Medical Systems, Inc. (NASDAQ:KRMD) today jointly announced an agreement leveraging KORU Medical's... ► Artikel lesen | |
| 13.08. | KORU Medical auf Wachstumskurs: Internationale Expansion und neue Produkte im Fokus | 1 | Investing.com Deutsch | ||
| 07.08. | Koru Medical Systems übertrifft im zweiten Quartal 2025 die Erwartungen | 1 | Investing.com Deutsch | ||
| 07.08. | KORU Medical Systems raises 2025 revenue outlook to $39.5M-$40.5M with accelerating international growth and new drug pipeline milestones | 1 | Seeking Alpha | ||
| 06.08. | KORU Medical Systems, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 07.07. | KORU Medical appoints Adam Kalbermatten as chief commercial officer | 1 | Investing.com | ||
| KORU MEDICAL SYSTEMS Aktie jetzt für 0€ handeln | |||||
| 11.06. | KORU Medical Systems to join Russell 3000 and 2000 indexes | 1 | Seeking Alpha | ||
| 15.05. | KORU Medical Systems, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 07.05. | KORU Medical Q1 2025 presentation: 18% revenue growth, raises full-year guidance | 1 | Investing.com | ||
| 07.05. | KORU Medical Systems, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 07.05. | KORU Medical Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.04. | KORU Medical Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.01. | KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter | 146 | Business Wire | MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization... ► Artikel lesen | |
| 13.11.24 | KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance | 137 | Business Wire |
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PRIVIA HEALTH GROUP | 24,460 | -2,08 % | Privia Health Group, Inc.: Privia Health Reports Second Quarter 2025 Financial Results | Very Strong First Half Performance Across All Key Operating and Financial MetricsImplemented Providers +13.8% and Practice Collections +18.5% compared to 2Q'24Guidance Raised to Above High End of... ► Artikel lesen | |
| GENEDX | 117,37 | 0,00 % | GeneDx announces first genomic newborn screening initiative | ||
| PROCEPT BIOROBOTICS | 34,800 | 0,00 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 16,045 | -4,61 % | Alignment Healthcare USA, LLC: Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for Seniors | ORANGE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage (MA) plan from Alignment Health, today announced its 2026 product portfolio, offering 68... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 28,730 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| HEARTFLOW | 36,140 | 0,00 % | HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis | ||
| BETA BIONICS | 20,490 | +1,39 % | Forecasting The Future: 4 Analyst Projections For Beta Bionics | ||
| SIEMENS HEALTHINEERS | 47,030 | +0,26 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers mit einem Kursziel von 61,30 Euro auf "Overweight" belassen. Die Ergebniserwartungen an das neue Geschäftsjahr... ► Artikel lesen | |
| AIRSCULPT TECHNOLOGIES | 7,960 | 0,00 % | Airsculpt Technologies, Inc.: AirSculpt Technologies Reports First Quarter Fiscal 2025 Results and Full Year Guidance | MIAMI BEACH, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen | |
| MIMEDX | 6,710 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results | Highest Quarterly Net Sales in MIMEDX History Second Quarter Net Sales of $99 million Grew 13% Year-Over-Year Second Quarter GAAP Net Income and Diluted Earnings Per Share were $10 Million and $0.06... ► Artikel lesen | |
| RXSIGHT | 8,560 | 0,00 % | Pre-market Movers: Basel Medical Group, SOBR Safe, ProKidney, RxSight, Mustang Bio | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green Basel Medical Group Ltd (BMGL) is up over 88% at... ► Artikel lesen | |
| PROGYNY | 20,540 | -3,20 % | A Healthcare Debate: Progyny vs. Hims & Hers | ||
| CLEARPOINT NEURO | 25,040 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System | New Product Category Will Enable Added Flexibility to Support Commercial Launches of Cell and Gene Therapy SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 1, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT)... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 83,00 | 0,00 % | Elutia closes $88M bioenvelope sale to Boston Scientific | ||
| GERRESHEIMER | 36,600 | 0,00 % | Gerresheimer, dynaCERT, Volkswagen - Spannende Entwicklungen! | Nachrichten machen Kurse. Das Pendel kann aber in beide Richtungen schwingen. Für informierte Anleger ist die richtige Interpretation der Ereignisse von entscheidender Bedeutung. Oft ergeben sich dann... ► Artikel lesen |
Das Unternehmen KORU MEDICAL SYSTEMS INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 3,790 Euro und damit -1,17 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu KORU MEDICAL SYSTEMS INC finden Sie auf Wallstreet Online.